These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3678278)

  • 1. Application of a new test for vitamin E deficiency to cystic fibrosis.
    Cynamon HA; Isenberg JN
    Eur J Pediatr; 1987 Sep; 146(5):512-4. PubMed ID: 3678278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of vitamin E status in cholestatic children by conventional laboratory standards and a new functional assay.
    Cynamon HA; Isenberg JN
    J Pediatr Gastroenterol Nutr; 1987; 6(1):46-50. PubMed ID: 3794932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status.
    Cynamon HA; Isenberg JN; Nguyen CH
    Clin Chim Acta; 1985 Sep; 151(2):169-76. PubMed ID: 4042377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis.
    Biggemann B; Laryea MD; Schuster A; Griese M; Reinhardt D; Bremer HJ
    Scand J Gastroenterol Suppl; 1988; 143():135-41. PubMed ID: 3164500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E status and its determinants in patients with cystic fibrosis.
    Sapiejka E; Krzyżanowska-Jankowska P; Wenska-Chyży E; Szczepanik M; Walkowiak D; Cofta S; Pogorzelski A; Skorupa W; Walkowiak J
    Adv Med Sci; 2018 Sep; 63(2):341-346. PubMed ID: 30081288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term changes in erythrocyte alpha-tocopherol content of vitamin E-deficient patients with cystic fibrosis.
    Winklhofer-Roob BM; Shmerling DH; Schimek MG; Tuchschmid PE
    Am J Clin Nutr; 1992 Jan; 55(1):100-3. PubMed ID: 1728808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals.
    Winklhofer-Roob BM; Tuchschmid PE; Molinari L; Shmerling DH
    Am J Clin Nutr; 1996 May; 63(5):717-21. PubMed ID: 8615354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility to peroxide-induced haemolysis with normal vitamin E concentrations in cystic fibrosis.
    James DR; Alfaham M; Goodchild MC
    Clin Chim Acta; 1991 Dec; 204(1-3):279-90. PubMed ID: 1819470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis.
    Farrell PM; Bieri JG; Fratantoni JF; Wood RE; di Sant'Agnese PA
    J Clin Invest; 1977 Jul; 60(1):233-41. PubMed ID: 874086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vitamin E deficiency in cystic fibrosis].
    Muñoz C; Polanco I; Hernanz A; Carrasco S; Barea I; Murga ML; Arroba ML; Codoceo R
    An Esp Pediatr; 1987 Dec; 27(6):445-8. PubMed ID: 3447496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis.
    Rana M; Wong-See D; Katz T; Gaskin K; Whitehead B; Jaffe A; Coakley J; Lochhead A
    J Clin Pathol; 2014 Jul; 67(7):605-8. PubMed ID: 24711511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oxidative damage in cystic fibrosis patients.
    Domínguez C; Gartner S; Liñán S; Cobos N; Moreno A
    Biofactors; 1998; 8(1-2):149-53. PubMed ID: 9699024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selenium and vitamin E in mucoviscidosis].
    Foucaud P; Thérond P; Marchand M; Brion F; Demelier JF; Navarro J
    Arch Fr Pediatr; 1988; 45(6):383-6. PubMed ID: 3219038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen.
    Feranchak AP; Sontag MK; Wagener JS; Hammond KB; Accurso FJ; Sokol RJ
    J Pediatr; 1999 Nov; 135(5):601-10. PubMed ID: 10547249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation.
    Lancellotti L; D'Orazio C; Mastella G; Mazzi G; Lippi U
    Eur J Pediatr; 1996 Apr; 155(4):281-5. PubMed ID: 8777920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis.
    Sokol RJ; Heubi JE; Iannaccone ST; Bove KE; Balistreri WF
    N Engl J Med; 1984 May; 310(19):1209-12. PubMed ID: 6709026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E supplementation in people with cystic fibrosis.
    Okebukola PO; Kansra S; Barrett J
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009422. PubMed ID: 25489958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E supplementation in cystic fibrosis.
    Peters SA; Kelly FJ
    J Pediatr Gastroenterol Nutr; 1996 May; 22(4):341-5. PubMed ID: 8732895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E status in preterm infants: assessment by plasma and erythrocyte vitamin E-lipid ratios and hemolysis tests.
    van Zoeren-Grobben D; Jacobs NJ; Houdkamp E; Lindeman JH; Drejer DF; Berger HM
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):73-9. PubMed ID: 9443124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.